CASTIGLIONE, VINCENZO
CASTIGLIONE, VINCENZO
Scuola Sup. di Studi Univ. e Perfezionamento S.Anna di PISA
[Central apneas and cardiovascular diseases]
2023-01-01 Gentile, Francesco; Sciarrone, Paolo; Buoncristiani, Francesco; Castiglione, Vincenzo; Bramanti, Francesca; Iudice, Giovanni; Poletti, Roberta; Passino, Claudio; Emdin, Michele; Giannoni, Alberto
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells]
2023-01-01 Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Emdin, Michele
A simple echocardiographic score to rule out cardiac amyloidosis
2020-01-01 Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M.
A simple echocardiographic score to rule out cardiac amyloidosis
2021-01-01 Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M.
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi
2023-01-01 Aimo, Alberto; Castiglione, Vincenzo; Fabiani, Iacopo; Morfino, Paolo; Emdin, Michele; Ferrari, Roberto; Tavazzi, Luigi; Maggioni, Aldo Pietro; Rapezzi, Claudio
Atrial amyloidosis: mechanisms and clinical manifestations
2022-01-01 Vergaro, G.; Aimo, A.; Rapezzi, C.; Castiglione, V.; Fabiani, I.; Pucci, A.; Buda, G.; Passino, C.; Lupon, J.; Bayes-Genis, A.; Emdin, M.; Braunwald, E.
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio
2024-01-01 Emdin, Michele; Aimo, Alberto; Vergaro, Giuseppe; Castiglione, Vincenzo
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
2022-01-01 Chianca, M.; Panichella, G.; Fabiani, I.; Giannoni, A.; L'Abbate, S.; Aimo, A.; Del Franco, A.; Vergaro, G.; Grigoratos, C.; Castiglione, V.; Cipolla, C. M.; Fedele, A.; Passino, C.; Emdin, M.; Cardinale, D. M.
Biomarkers for the diagnosis and management of heart failure
2021-01-01 Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M.
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides
2021-01-01 Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C.
Biomarkers for the diagnosis and management of heart failure: New frontiers
2021-01-01 Vergaro, G.; Castiglione, V.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Giannelli, E.; Maltinti, M.; Passino, C.; Emdin, M.
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
2022-01-01 Bayes-Genis, Antoni; Aimo, Alberto; Jhund, Pardeep; Richards, Mark; de Boer, Rudolf A; Arfsten, Henrike; Fabiani, Iacopo; Lupón, Josep; Anker, Stefan D; González, Arantxa; Castiglione, Vincenzo; Metra, Marco; Mueller, Christian; Núñez, Julio; Rossignol, Patrick; Barison, Andrea; Butler, Javed; Teerlink, John; Filippatos, Gerasimos; Ponikowski, Piotr; Vergaro, Giuseppe; Zannad, Faiez; Seferovic, Petar; Rosano, Giuseppe; Coats, Andrew J S; Emdin, Michele; Januzzi, James L
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
2022-01-01 Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Vergaro, Giuseppe; Emdin, Michele; Clerico, Aldo
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
2021-01-01 Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.
Cardiac magnetic resonance in patients with muscular dystrophies
2020-01-01 Grigoratos, C.; Aimo, A.; Barison, A.; Castiglione, V.; Todiere, G.; Ricci, G.; Siciliano, G.; Emdin, M.
Cardiovascular disease and COVID-19: les liaisons dangereuses
2020-01-01 Barison, A.; Aimo, A.; Castiglione, V.; Arzilli, C.; Lupon, J.; Codina, P.; Santiago-Vacas, E.; Cediel, G.; Emdin, M.; Bayes-Genis, A.
Cardiovascular toxicity from therapies for light chain amyloidosis
2023-01-01 Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Chianca, Michela; Vergaro, Giuseppe; Cipolla, Carlo Maria; Fedele, Antonella; Emdin, Michele; Fabiani, Iacopo; Cardinale, Daniela
Coronary Artery Anomalies
2021-01-01 Gentile, F.; Castiglione, V.; De Caterina, R.
Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician
2024-01-01 Castiglione, Vincenzo; Aimo, Alberto; Vergaro, Giuseppe
Critical Reading of cardiovascular trials with neutral or negative results
2023-01-01 Rapezzi, Claudio; Aimo, Alberto; Fabiani, Iacopo; Castiglione, Vincenzo; Ferrari, Roberto; Maggioni, Aldo Pietro; Tavazzi, Luigi
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
[Central apneas and cardiovascular diseases] | 1-gen-2023 | Gentile, Francesco; Sciarrone, Paolo; Buoncristiani, Francesco; Castiglione, Vincenzo; Bramanti, Francesca; Iudice, Giovanni; Poletti, Roberta; Passino, Claudio; Emdin, Michele; Giannoni, Alberto | |
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] | 1-gen-2023 | Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Emdin, Michele | |
A simple echocardiographic score to rule out cardiac amyloidosis | 1-gen-2020 | Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M. | |
A simple echocardiographic score to rule out cardiac amyloidosis | 1-gen-2021 | Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M. | |
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi | 1-gen-2023 | Aimo, Alberto; Castiglione, Vincenzo; Fabiani, Iacopo; Morfino, Paolo; Emdin, Michele; Ferrari, Roberto; Tavazzi, Luigi; Maggioni, Aldo Pietro; Rapezzi, Claudio | |
Atrial amyloidosis: mechanisms and clinical manifestations | 1-gen-2022 | Vergaro, G.; Aimo, A.; Rapezzi, C.; Castiglione, V.; Fabiani, I.; Pucci, A.; Buda, G.; Passino, C.; Lupon, J.; Bayes-Genis, A.; Emdin, M.; Braunwald, E. | |
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio | 1-gen-2024 | Emdin, Michele; Aimo, Alberto; Vergaro, Giuseppe; Castiglione, Vincenzo | |
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers | 1-gen-2022 | Chianca, M.; Panichella, G.; Fabiani, I.; Giannoni, A.; L'Abbate, S.; Aimo, A.; Del Franco, A.; Vergaro, G.; Grigoratos, C.; Castiglione, V.; Cipolla, C. M.; Fedele, A.; Passino, C.; Emdin, M.; Cardinale, D. M. | |
Biomarkers for the diagnosis and management of heart failure | 1-gen-2021 | Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M. | |
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides | 1-gen-2021 | Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C. | |
Biomarkers for the diagnosis and management of heart failure: New frontiers | 1-gen-2021 | Vergaro, G.; Castiglione, V.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Giannelli, E.; Maltinti, M.; Passino, C.; Emdin, M. | |
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology | 1-gen-2022 | Bayes-Genis, Antoni; Aimo, Alberto; Jhund, Pardeep; Richards, Mark; de Boer, Rudolf A; Arfsten, Henrike; Fabiani, Iacopo; Lupón, Josep; Anker, Stefan D; González, Arantxa; Castiglione, Vincenzo; Metra, Marco; Mueller, Christian; Núñez, Julio; Rossignol, Patrick; Barison, Andrea; Butler, Javed; Teerlink, John; Filippatos, Gerasimos; Ponikowski, Piotr; Vergaro, Giuseppe; Zannad, Faiez; Seferovic, Petar; Rosano, Giuseppe; Coats, Andrew J S; Emdin, Michele; Januzzi, James L | |
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond | 1-gen-2022 | Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Vergaro, Giuseppe; Emdin, Michele; Clerico, Aldo | |
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient | 1-gen-2021 | Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M. | |
Cardiac magnetic resonance in patients with muscular dystrophies | 1-gen-2020 | Grigoratos, C.; Aimo, A.; Barison, A.; Castiglione, V.; Todiere, G.; Ricci, G.; Siciliano, G.; Emdin, M. | |
Cardiovascular disease and COVID-19: les liaisons dangereuses | 1-gen-2020 | Barison, A.; Aimo, A.; Castiglione, V.; Arzilli, C.; Lupon, J.; Codina, P.; Santiago-Vacas, E.; Cediel, G.; Emdin, M.; Bayes-Genis, A. | |
Cardiovascular toxicity from therapies for light chain amyloidosis | 1-gen-2023 | Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Chianca, Michela; Vergaro, Giuseppe; Cipolla, Carlo Maria; Fedele, Antonella; Emdin, Michele; Fabiani, Iacopo; Cardinale, Daniela | |
Coronary Artery Anomalies | 1-gen-2021 | Gentile, F.; Castiglione, V.; De Caterina, R. | |
Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician | 1-gen-2024 | Castiglione, Vincenzo; Aimo, Alberto; Vergaro, Giuseppe | |
Critical Reading of cardiovascular trials with neutral or negative results | 1-gen-2023 | Rapezzi, Claudio; Aimo, Alberto; Fabiani, Iacopo; Castiglione, Vincenzo; Ferrari, Roberto; Maggioni, Aldo Pietro; Tavazzi, Luigi |